Molecular Profiles, a UK-based provider of pharmaceutical development and manufacturing services, will host a seminar this week focused on overcoming biological barriers in drug development. The conference is the second of its kind hosted by Molecular Profiles and will be held at the Belfry Hotel in Nottingham on January 21 and 22, 2014.

The company will welcome pharmaceutical executives and scientists for the two-day conference that aims to give an overview on the latest research in drug targeting and delivery for all routes of administration. Keynote speakers for the industry-led event include Professor Clive Wilson, Professor Jonathan Hadgraft, Professor Ijeoma Uchegbu and Professor Randy Mrsny.

Commenting on the event, Molecular Profiles’ chief technical officer Dr. Robert Harris said, “We wanted to build upon the success of our event two years ago and mark the start of an exciting phase in the growth of our company with the opening of our new GMP facility by focusing on one of the key challenges in drug product development – overcoming the challenges of achieving bioavailability in the human body. The presentations will cover all aspects of drug delivery, from targeting to specific cells and locations in the body, to the advances in efficient delivery of drugs into the body.”

Attendees will also be given a tour of Molecular Profiles’ new clinical manufacturing facility, which opened last year, prior to the company’s acquisition by Boston, MA-based Columbia Laboratories. The new facility enables manufacturing of a range of dosage forms such as solids, liquids, semi-solids and inhaled products, including the capability for manufacture of highly potent compounds.

To attend “Overcoming Biological Barriers: A discussion of the challenges of formulating for success” on Jan. 21-22, 2014, contact Ailsa Pearson at Molecular Profiles at +44 (0) 115 871 8887 or apierson@molprofiles.co.uk